Overview

A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing

Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the feasibility, safety, and tolerability of administering ZYC300 with Cyclophosphamide (Cytoxan).
Phase:
Phase 1
Details
Lead Sponsor:
Eisai Inc.
Treatments:
Cyclophosphamide